AMicale des COXiens

Forum des actionnaires particuliers de NicOx
 
AccueilAccueil  GalerieGalerie  S'enregistrerS'enregistrer  ConnexionConnexion  

Partagez | 
 

 NICOX ET PFIZER NCX 139

Voir le sujet précédent Voir le sujet suivant Aller en bas 
AuteurMessage
Seb

avatar

Nombre de messages : 751
Age : 45
Localisation : 64122 URRUGNE
Date d'inscription : 27/08/2010

MessageSujet: NICOX ET PFIZER NCX 139   Mer 7 Déc - 0:35

14-17 Septembre 2011

35° Congresso Nazionale della Società Italiana di Farmacologia .


Ocular hypotensive effects of NCX 139, a nitric oxide (NO)-donating latanoprost amide, in normotensive and ocular hypertensive rabbits and dogs

Authors
F. Impagnatiello1, V. Borghi1, F. Benedini1, S.T. Carreiro2, W.K.M. Chong2, G. Prasanna2, A.H.P. Krauss2 and E. Ongini1

1NicOx Research Institute, Bresso, Milan, Italy
2Pfizer Global Research & Development-La Jolla, San Diego, USA

Abstract
Nitric oxide (NO) signaling regulates intraocular pressure (IOP) and regional eye blood flow with mechanisms complementary to those of prostamides and prostaglandins. NCX 139 is a novel compound comprising latanoprost amide and a NO-donating moiety which we recently synthesized to achieve greater IOP lowering and improved ocular perfusion compared to currently approved medications in glaucoma therapy.
NCX 139 was synthesized in house and later characterized with respect to its NO and prostaglandin-F (FP) binding properties. We also determined the IOP-lowering effects of this drug in rabbit and dog models of hypertensive glaucoma. The respective des-nitro analog as well as the prostamide, bimatoprost and the prostaglandin, latanoprost, were included for comparison.
NCX 139 but not its des-nitro analog resulted in selective NO-mediated vascular relaxant effect (EC50 = 0.70 ±0.06 microM; Emax= 80.6 ±2.9%). Like bimatoprost (IC50=3.07 ± 1.3microM), NCX 139 displaced 3H-PGF2alpha binding to human FP receptors with an estimated potency of 0.77 ± 0.13 microM.
In transiently ocular hypertensive rabbits which are not responsive to prostaglandin and prostamide mimetics, NCX 139 significantly lowered IOP while the des-nitro analog was not effective (0.03% NCX 139, Deltamax= -12.8 ±2.0 mmHg) suggesting a direct contribution of NO in this model. In glaucomatous dogs, NCX 139 decreased the IOP to greater extent compared to the des-nitro analog (Deltamax= -4.6 ±1.0 and -2.7 ±1.3 mmHg for NCX 139 and its des-nitro analog, respectively). In this model, both bimatoprost and latanoprost also resulted effective.
The data suggest that NCX 139 has potent ocular hypotensive activity in the rabbit and dog elevated IOP models. These effects are likely dependent on two mechanisms involving NO and FP signalling.
Revenir en haut Aller en bas
Voir le profil de l'utilisateur
Seb

avatar

Nombre de messages : 751
Age : 45
Localisation : 64122 URRUGNE
Date d'inscription : 27/08/2010

MessageSujet: Re: NICOX ET PFIZER NCX 139   Mer 7 Déc - 0:37

Merci genevagenf! c'est grâce à toi que j'ai trouvé sante
Revenir en haut Aller en bas
Voir le profil de l'utilisateur
 
NICOX ET PFIZER NCX 139
Voir le sujet précédent Voir le sujet suivant Revenir en haut 
Page 1 sur 1
 Sujets similaires
-
» EUR/USD NEWS 20.02.2012
» EUR/USD NEWS 17.02.2012

Permission de ce forum:Vous ne pouvez pas répondre aux sujets dans ce forum
AMicale des COXiens :: Forum public :: Echanges sur NicOx-
Sauter vers: